Clinical Trial Update: A Clinical Trial to Evaluate the Clinical Efficacy of Cyclosporine 0.1% (Ikervis®) for Moderate to Severe Dry Eye Patients. (IKE-03-SWITCHING) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of cyclosporine 0.1% (Ikervis) for moderate to severe dry eye; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• To Severe Dry Eye

Drugs mentioned

• Ikervis (ciclosporin ophthalmic emulsion)

Snippet

Sponsor: Yonsei University | Conditions: Moderate to Severe Dry Eye | Phase 4 | Status: UNKNOWN